From Living BLISSfully to BEATing Lupus: Future Considerations for Biologic Therapy in SLE - Rheumatology Network
5/9/2022 12:00:00 AM2 years 11 months ago
by Chris Wincup, MBBS, BSc
by Chris Wincup, MBBS, BSc
After years of frustration and failure, trials of targeted biologic therapy in systemic lupus erythematosus are beginning to show success. New drugs, including anifrolumab (Saphnelo) and belimumab (Benlysta), are paving the way for an exciting new era. Howeve…
Clinical trials aiming to evaluate the efficacy and safety of new agents in the management of lupus have long been a thorny subject. Despite initial promise, Rituximab (a chimeric monoclonal antibody… [+6797 chars]
full article...